Medical Devices & Tech

Medlogics Device Corporation

3589 Westwind Boulevard
Santa Rosa, CA 95403
Click for website

Research Sector Medical Devices & Tech

Summary Description Vertically Integrated Drug Eluting Coating, Stent and Catheter Research, Development and Manufacturing

Management Richard Klein, President; Majid Akhavan, Director, Analytical Chemistry; Kenneth J. Colley, M.D., Ph.D., Vice President, Pharmaceutical Product Development; Kendra Des-Bordes, Director, Operations; Kendra Des-Bordes, Director, Operations; Michael J. Lee, Vice President, Engineering; Joseph R. Tamayo, Vice President, Regulatory Affairs and Quality Assurance; John (Jack) Thomas, RN, Vice-President, Clinical Affairs

Click here for Financial Data
Keywords: stent, drug delivery, cardiology, stenosis, Cobra


Updated: Aug. 22, 2013


Medlogics is an early-stage medical device company developing a broad platform technology for drug delivery. Specifically, it is creating next-generation drug eluting stent technology using novel drug......view more

Products / Services

Medlogics' initial focus is on product development of polymer-free stent drug delivery.The Cobra Coronary Stent System combines a unique design with an advanced cobalt super alloy. Cobra's advanced ar......view more

Technology / Differentiation

Quantitative coronary angiography results from chronic pre-clinical testing of Cobra implants have demonstrated a statistically significant reduction in stenosis, with results nearing typical drug elu...view more

Market / Customers

The global stent market currently exceeds $5 billion, and is expected to grow to $7 billion by 2010.......view more


The company's near term objectives include the international launch of the Cobra, as well as the pivotal trial for its PMA approval and obtaining one-year follow-up data from multiple arms of first-in...view more